Compare SRPT & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRPT | LION |
|---|---|---|
| Founded | 1980 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 1997 | N/A |
| Metric | SRPT | LION |
|---|---|---|
| Price | $21.14 | $8.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 10 |
| Target Price | ★ $26.23 | $9.11 |
| AVG Volume (30 Days) | ★ 3.3M | 2.5M |
| Earning Date | 11-03-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,413,715,000.00 | ★ $3,858,000,000.00 |
| Revenue This Year | $13.83 | N/A |
| Revenue Next Year | N/A | $22.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.15 | 21.18 |
| 52 Week Low | $10.42 | $5.55 |
| 52 Week High | $129.84 | $9.24 |
| Indicator | SRPT | LION |
|---|---|---|
| Relative Strength Index (RSI) | 52.56 | 67.41 |
| Support Level | $20.14 | $7.55 |
| Resistance Level | $22.97 | $8.75 |
| Average True Range (ATR) | 1.25 | 0.39 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 53.22 | 72.51 |
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.